Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary

Acta Obstetricia et Gynecologica Scandinavica

Volumn 88, Issue 11, 2009, Pages 1288-1290

  Kasenda, Benjamin ^a,b   Harter, Philipp ^c   Hirsch, Tobias ^b   Ast, Alexander ^b   Buhrmann, Christine ^c   Glaser, Florian ^b   Du Bois, Andreas ^c  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF WITTEN HERDECKE   (Germany)

^c DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Dysgerminoma; Lymph node metastasis; Non epithelial ovarian cancer; Surgery for relapse

Indexed keywords

BLEOMYCIN; CISPLATIN; ETOPOSIDE;

ADULT; APPENDECTOMY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CLINICAL ASSESSMENT; DYSGERMINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LAPAROTOMY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MULTIPLE CYCLE TREATMENT; OMENTECTOMY; OVARIECTOMY; PARAAORTIC LYMPH NODE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TRANSVAGINAL ECHOGRAPHY; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; DYSGERMINOMA; ETOPOSIDE; FEMALE; HUMANS; LYMPHATIC METASTASIS; OVARIAN NEOPLASMS; PERITONEAL NEOPLASMS; YOUNG ADULT;

EID: 70449557036     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.3109/00016340903242461     Document Type: Article

References (12)

1. Culine S, Lhomme C, Kattan J, Duvillard P, Michel G, Gerbaulet A, et al. Cisplatin-based chemotherapy in dysgerminoma of the ovary: Thirteen-year experience at the Institut Gustave Roussy. Gynecol Oncol. 1995;58:344-348
2. Subramanian A, Rohatgi A. An unusual presentation of a malignant dysgerminoma. Int J Clin Pract. 2007;61:1046-1047
3. Parkash V, Carcangiu ML. Transformation of ovarian dysgerminoma to yolk sac tumor: Evidence for a histogenetic continuum. Mod Pathol. 1995;8:881-887
4. Komission OVAR, AGOe.V. Interdisziplinäre S2k-Leitlinie für die Diagnostik und Therapie maligner Ovarialtumoren [Interdisciplinary S2k-guidelines for diagnostics and therapy for malignant tumors of the ovary]. Munich, Germany: Zuckschwerdt Verlag; 2007.
5. Mitchell MF, Gershenson DM, Soeters RP, Eifel PJ, Delclos L, Wharton JT. The long-term effects of radiation therapy on patients with ovarian dysgerminoma. Cancer. 1991;67:1084-1090
6. Stier EA, Barakat RR, Curtin JP, Brown CL, Jones WB, Hoskins WJ. Laparotomy to complete staging of presumed early ovarian cancer. Obstet Gynecol. 1996;87:737-740
7. Harter P, Gnauert K, Hils R, Lehmann TG, Fisseler- Eckhoff A, Traut A, et al. Pattern and clinical predictors of lymph node metastases in epithelial ovarian cancer. Int J Gynecol Cancer. 2007;17:1238-1244
8. Williams SD, Kauderer J, Burnett AF, Lentz SS, Aghajanian C, Armstrong DK. Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: A trial of the Gynecologic Oncology Group. Gynecol Oncol. 2004;95:496-499
9. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL, et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J Clin Oncol. 1990;8:715-720
10. Gershenson DM, Wharton JT, Kline RC, Larson DM, Kavanagh JJ, Rutledge FN. Chemotherapeutic complete remission in patients with metastatic ovarian dysgerminoma. Potential for cure and preservation of reproductive capacity. Cancer. 1986;58:2594-2599
11. Behtash N, Karimi Zarchi M. Dysgerminoma in three patients with Swyer syndrome. World J Surg Oncol. 2007;5:71.
12. Zielinska D, Zajaczek S, Rzepka-Gorska I. Tumors of dysgenetic gonads in Swyer syndrome. J Pediatr Surg. 2007;42:1721-1724